Elham Jamshidi

Dr. Elham Jamshidi

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2022 in The Lancet Regional Health - Europe
Verified
Journal Article
Open access
Giulio CastelpietraGiulio Castelpietra
Giulio Castelpietra
AKAnn Kristin Skrindo Knudsen
Ann Kristin Skrindo Knudsen
EAEmilie E. Agardh
Emilie E. Agardh
BABenedetta Armocida
Benedetta Armocida
MBMassimiliano Beghi
Massimiliano Beghi
Lorenzo MonastaLorenzo Monasta
Lorenzo Monasta
Mental health is a public health issue for European young people, with great heterogeneity in resource allocation. Representative population-based studies are needed. The Global Burden of Disease (GBD) Study 2019 provides internationally comparable information on trends in the health status of populations and changes in the leading causes of disease burden over time. Prevalence, incidence, Years Lived with Disability (YLDs) and Years of Life Lost (YLLs) from mental disorders (MDs), substance use disorders (SUDs) and self-harm were estimated for young people aged 10-24 years in 31 European countries. Rates per 100,000 population, percentage changes in 1990-2019, 95% Uncertainty Intervals (UIs), and correlations with Sociodemographic Index (SDI), were estimated. In 2019, rates per 100,000 population were 16,983 (95% UI 12,823 – 21,630) for MDs, 3,891 (3,020 - 4,905) for SUDs, and 89·1 (63·8 - 123·1) for self-harm. In terms of disability, anxiety contributed to 647·3 (432–912·3) YLDs, while in terms of premature death, self-harm contributed to 319·6 (248·9–412·8) YLLs, per 100,000 population. Over the 30 years studied, YLDs increased in eating disorders (14·9%;9·4-20·1) and drug use disorders (16·9%;8·9-26·3), and decreased in idiopathic developmental intellectual disability (–29·1%;23·8-38·5). YLLs decreased in self-harm (–27·9%;38·3-18·7). Variations were found by sex, age-group and country. The burden of SUDs and self-harm was higher in countries with lower SDI, MDs were associated with SUDs. Mental health conditions represent an important burden among young people living in Europe. National policies should strengthen mental health, with a specific focus on young people. The Bill and Melinda Gates Foundation

23 July 2020 in Frontiers in Bioengineering and Biotechnology
Verified
Journal Article
Open access
PDF file
ABAmirhesam Babajani
Amirhesam Babajani
PSPegah Soltani
Pegah Soltani
EJElham Jamshidi
Elham Jamshidi
MFMohammad Hadi Farjoo
Mohammad Hadi Farjoo
HNHassan Niknejad
Hassan Niknejad
Mesenchymal stem cells (MSCs), as an undifferentiated group of adult multipotent cells, have remarkable antitumor features that bring them up as a novel choice to treat cancers. MSCs are capable of altering the behavior of cells in the tumor microenvironment, inducing an anti-inflammatory effect in tumor cells, inhibiting tumor angiogenesis, and preventing metastasis. Besides, MSCs can induce apoptosis and inhibit the proliferation of tumor cells. The ability of MSCs to be loaded with chemotherapeutic drugs and release them in the site of primary and metastatic neoplasms makes them a preferable choice as targeted drug delivery procedure. Targeted drug delivery minimizes unexpected side effects of chemotherapeutic drugs and improves clinical outcomes. This review focuses on recent advances on innate antineoplastic features of MSCs and the effect of chemotherapeutic drugs on viability, proliferation, and the regenerative capacity of various kinds of MSCs. It also discusses the efficacy and mechanisms of drug loading and releasing procedures along with in vivo and in vitro preclinical outcomes of antineoplastic effects of primed MSCs for clinical prospection.

1 October 2021 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
KMKasra Moeinabadi-Bidgoli
Kasra Moeinabadi-Bidgoli
ABAmirhesam Babajani
Amirhesam Babajani
GYGhasem Yazdanpanah
Ghasem Yazdanpanah
BFBehrouz Farhadihosseinabadi
Behrouz Farhadihosseinabadi
EJElham Jamshidi
Elham Jamshidi
HNHassan Niknejad
Hassan Niknejad
Cell-based therapy (CBT) is a revolutionary approach for curing a variety of degenerative diseases. Stem cell-based regenerative medicine is a novel strategy for treating tissue damages regarding stem cells unique properties such as differentiation potential, paracrine impacts, and self-renewal ability. However, the current cell-based treatments encounter considerable challenges to be translated into clinical practice, including low cell survival, migration, and differentiation rate of transplanted stem cells. The poor stem cell therapy outcomes mainly originate from the unfavorable condition of damaged tissues for transplanted stem cells. The promising method of preconditioning improves cell resistance against the host environment's stress by imposing certain conditions similar to the harsh microenvironment of the damaged tissues on the transplanted stem cells. Various pharmacological, biological, and physical inducers are able to establish preconditioning. In addition to their known pharmacological effects on tissues and cells, these preconditioning agents improve cell biological aspects such as cell survival, proliferation, differentiation, migration, immunomodulation, paracrine impacts, and angiogenesis. This review focuses on different protocols and inducers of preconditioning along with underlying molecular mechanisms of their effects on stem cell behavior. Moreover, preclinical applications of preconditioned stem cells in various damaged organs such as heart, lung, brain, bone, cartilage, liver, and kidney are discussed with prospects of their translation into the clinic.

5 January 2021 in Neurocritical Care
Verified
Journal Article
Closed access
PDF file
MEMaryam Edalatfar
Maryam Edalatfar
SPSeyed Mohammad Piri
Seyed Mohammad Piri
MMMohammad-Mehdi Mehrabinejad
Mohammad-Mehdi Mehrabinejad
MMMonireh-Sadat Mousavi
Monireh-Sadat Mousavi
SMSogol Meknatkhah
Sogol Meknatkhah
MSMahdi Sharif-Alhoseini
Mahdi Sharif-Alhoseini

11 January 2021 in Stem Cell Reviews and Reports
Verified
Journal Article
Closed access
PDF file
EJElham Jamshidi
Elham Jamshidi
ABAmirhesam Babajani
Amirhesam Babajani
PSPegah Soltani
Pegah Soltani
HNHassan Niknejad
Hassan Niknejad

13 January 2022 in Frontiers in Digital Health
Verified
Journal Article
Open access
EJElham Jamshidi
Elham Jamshidi
AAAmirhossein Asgary
Amirhossein Asgary
NTNader Tavakoli
Nader Tavakoli
AZAlireza Zali
Alireza Zali
SSSoroush Setareh
Soroush Setareh
NMNahal Mansouri
Nahal Mansouri
Rationale: Given the expanding number of COVID-19 cases and the potential for new waves of infection, there is an urgent need for early prediction of the severity of the disease in intensive care unit (ICU) patients to optimize treatment strategies.Objectives: Early prediction of mortality using machine learning based on typical laboratory results and clinical data registered on the day of ICU admission.Methods: We retrospectively studied 797 patients diagnosed with COVID-19 in Iran and the United Kingdom (U.K.). To find parameters with the highest predictive values, Kolmogorov-Smirnov and Pearson chi-squared tests were used. Several machine learning algorithms, including Random Forest (RF), logistic regression, gradient boosting classifier, support vector machine classifier, and artificial neural network algorithms were utilized to build classification models. The impact of each marker on the RF model predictions was studied by implementing the local interpretable model-agnostic explanation technique (LIME-SP).Results: Among 66 documented parameters, 15 factors with the highest predictive values were identified as follows: gender, age, blood urea nitrogen (BUN), creatinine, international normalized ratio (INR), albumin, mean corpuscular volume (MCV), white blood cell count, segmented neutrophil count, lymphocyte count, red cell distribution width (RDW), and mean cell hemoglobin (MCH) along with a history of neurological, cardiovascular, and respiratory disorders. Our RF model can predict patient outcomes with a sensitivity of 70% and a specificity of 75%. The performance of the models was confirmed by blindly testing the models in an external dataset.Conclusions: Using two independent patient datasets, we designed a machine-learning-based model that could predict the risk of mortality from severe COVID-19 with high accuracy. The most decisive variables in our model were increased levels of BUN, lowered albumin levels, increased creatinine, INR, and RDW, along with gender and age. Considering the importance of early triage decisions, this model can be a useful tool in COVID-19 ICU decision-making.